Detalhe da pesquisa
1.
Infliximab Concentrations during Induction Are Predictive for Endoscopic Remission in Pediatric Patients with Inflammatory Bowel Disease under Combination Therapy.
J Pediatr
; 240: 150-157.e4, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34481805
2.
Modelling of the relationship between infliximab exposure, faecal calprotectin and endoscopic remission in patients with Crohn's disease.
Br J Clin Pharmacol
; 87(1): 106-118, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32415677
3.
The effect of aging on infliximab exposure and response in patients with inflammatory bowel diseases.
Br J Clin Pharmacol
; 87(10): 3776-3789, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33604964
4.
Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region.
Proc Natl Acad Sci U S A
; 115(8): 1901-1906, 2018 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29432186
5.
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease.
Clin Gastroenterol Hepatol
; 18(3): 637-646.e11, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31128336
6.
Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients.
J Clin Gastroenterol
; 54(9): 819-825, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31789759
7.
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.
Gastroenterology
; 154(5): 1343-1351.e1, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29317275
8.
Optimising infliximab induction dosing for patients with ulcerative colitis.
Br J Clin Pharmacol
; 85(4): 782-795, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30634202
9.
Pharmacodynamic Monitoring of Biological Therapies in Chronic Inflammatory Diseases.
Ther Drug Monit
; 41(2): 131-141, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30883507
10.
Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel Disease.
Ther Drug Monit
; 41(3): 317-324, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30633088
11.
Comparison of Immunoassays for Measuring Serum Levels of Golimumab and Antibodies Against Golimumab in Ulcerative Colitis: A Retrospective Observational Study.
Ther Drug Monit
; 41(4): 459-466, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30817702
12.
Immunogenicity is not the driving force of treatment failure in vedolizumab-treated inflammatory bowel disease patients.
J Gastroenterol Hepatol
; 34(7): 1175-1181, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30589948
13.
Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease.
J Pediatr Gastroenterol Nutr
; 68(6): 847-853, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30633108
14.
Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial.
Gut
; 67(5): 818-826, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28450388
15.
Mucosal Healing and Long-term Outcomes of Patients With Inflammatory Bowel Diseases Receiving Clinic-Based vs Trough Concentration-Based Dosing of Infliximab.
Clin Gastroenterol Hepatol
; 16(8): 1276-1283.e1, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29203225
16.
Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 16(12): 1937-1946.e8, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29704680
17.
Characterization and Application of a Unique Panel of Monoclonal Antibodies Generated against Etanercept.
J Immunol
; 196(6): 2879-84, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26843328
18.
Immunoassay for Detection of Infliximab in Whole Blood Using a Fiber-Optic Surface Plasmon Resonance Biosensor.
Anal Chem
; 89(6): 3664-3671, 2017 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28222600
19.
Innovative thrombolytic strategy using a heterodimer diabody against TAFI and PAI-1 in mouse models of thrombosis and stroke.
Blood
; 125(8): 1325-32, 2015 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25540192
20.
The association between etanercept serum concentration and psoriasis severity is highly age-dependent.
Clin Sci (Lond)
; 131(11): 1179-1189, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28420676